Automatically selected top health news story of the day ( ? )
Follow us with Twitter - Facebook - RSS feed - Bookmark
Next update in hours

New immunotherapy combination tolerable, effective in patients with advanced kidney cancer

Medical Xpress - Sun 11 Feb 18

Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase ...

New immunotherapy combination tolerable, effective in patients with advanced kidney cancer, Eurekalert - Sat 10 Feb 18

Combo Therapy Highly Active in Untreated RCC

MedPageToday - Mon 12 Feb 18

(MedPage Today) -- Objective responses with anti-VEGF/Anti-PD-1 pairing in three-fourths of patients